Research & Development

干姐姐妹妹干狠狠干受召回影响 蔚来汽车7月交付低迷仅837辆


干姐姐   只是這口氣並不腥臭,反而帶著一股子清新的西瓜味道……妹妹干   “我本世上逍遙客,君是深閨夢里人!”   一盞孤燈從遠處走來,映照在湖面上就如同一顆飛行緩慢的流星。狠狠干   一盞孤燈從遠處走來,映照在湖面上就如同一顆飛行緩慢的流星。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo